Bullish indicating open at $55-$60, IPO prices at $37
BIRMINGHAM, Ala. and HASLET, Texas - Encompass Health Corp. (NYSE:EHC), an $11.75 billion healthcare provider showing robust 11.8% revenue growth over the last twelve months, announced plans to construct a 50-bed inpatient rehabilitation hospital in Haslet, Texas, according to a press release statement issued Thursday. InvestingPro analysis indicates the company maintains strong financial health with a "GREAT" overall rating.
The facility, expected to open in 2027, will provide specialized care for patients recovering from illnesses and injuries including strokes, neurological disorders, brain and spinal cord injuries, amputations, and complex orthopedic conditions. The expansion aligns with the company’s growth trajectory, which has caught analysts’ attention - InvestingPro data shows 8 analysts have recently revised their earnings expectations upward for the upcoming period.
The new hospital will feature private patient rooms, a therapy gym with advanced rehabilitation technologies, an activities of daily living suite, in-house dialysis, a pharmacy, and a therapy courtyard.
"We are excited to further expand Encompass Health’s presence in Texas," said Brad Kennedy, Encompass Health group president, in the statement.
The Haslet facility will join Encompass Health’s network of 169 rehabilitation hospitals across 38 states and Puerto Rico. The company describes itself as the largest owner and operator of inpatient rehabilitation hospitals in the United States. Trading near its 52-week high, Encompass Health has demonstrated consistent profitability and strong returns over the past decade. Discover more insights about EHC’s performance in the comprehensive Pro Research Report, available exclusively on InvestingPro.
The announcement includes typical forward-looking statements noting that actual results may differ from current plans due to regulatory reviews, potential delays, and other factors that could affect the project’s completion.
Encompass Health did not disclose the financial investment required for the new facility in its announcement.
In other recent news, Encompass Health Corp reported impressive financial results for the second quarter of 2025. The company announced earnings per share of $1.40, which exceeded analyst expectations of $1.21, representing a 15.7% surprise. Revenue figures were also strong, reaching $1.46 billion and surpassing the anticipated $1.43 billion. These results highlight the company’s robust performance during the quarter. Additionally, analysts have taken note of these developments, with some firms likely to reassess their ratings based on the latest financial data. Investors have shown confidence in Encompass Health following these announcements. These recent developments underscore the company’s ability to exceed market expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.